A cross-sectional report on melasma among Hispanic patients: Evaluating the role of oral tranexamic acid versus oral tranexamic acid plus hydroquinone - 10/10/20

Ileana E. Arreola Jauregui, MD ^a, Gabriel Huerta Rivera, MD ^a, Manuel Soria Orozco, MD ^{b, ⁎} , Silvia Meyer-Nava, MSc ^c, Juan E. Paniagua Santos, MD ^a, Juan B. López Zaldo, MD ^a, Ilse Meyer-Nava, MD ^a, Clara Madrid Carrillo, MD ^a, Iara E. Zaldo Rolón, MD ^a, Aline E. Baeza Echeverría, MD ^a, Minerva Vázquez Huerta, MD ^a

^a Derma Center Aesthetic Clinic Laser, Guadalajara, Mexico 

^b Department of Dermatology, Civil Hospital of Guadalajara, Guadalajara, Mexico 

^c Biotechnology Institute National Autonomous University of Mexico, Morelos Campus, Cuernavaca, Mexico 

^∗Correspondence to: Manuel Soria Orozco, MD, Department of Dermatology, Civil Hospital of Guadalajara, Av Hospital 278, Sector Hidalgo, CP 44280, Guadalajara, Jalisco MexicoDepartment of DermatologyCivil Hospital of GuadalajaraAv Hospital 278, Sector HidalgoGuadalajaraJaliscoCP 44280Mexico